Medical Advocates

HIV Infection/Disease
  Pre-Exposure Prophylaxis

General Reports
Special Populations
Ethical Challenges
Drugs
Videos



 

HIV Prevention Main Page Main New/Newsworthy Home Page

Last Update:  September 14, 2017
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader


General Reports
     

     Internet Documents
 
  PDF DOCUMENT
Who’s prepared to make PrEP work?
Mascolini  M
RITA Winter 2012
(features two comprehensive reviews of preexposure prophylaxis (PrEP) and interviews with two PrEP experts)
Document

       Journal Papers, Abstracts, and Commentaries    
 

 

HIV pre-exposure prophylaxis implementation at local health departments: a statewide assessment of activities and barriers.
Zhang HL, Rhea SK, Hurt CB,
et al
J Acquir Immune Defic Syndr
. 2017 Sep 11.
Abstract

Examining the Impact of Intimate Partner Violence Type and Timing on Pre-exposure Prophylaxis Awareness, Interest, and Coercion.
Willie TC, Stockman JK, Overstreet NM, Kershaw TS.

AIDS Behav
. 2
Abstract

Developing a Web-Based Geolocated Directory of HIV Pre-Exposure Prophylaxis-Providing Clinics: The PrEP Locator Protocol and Operating Procedures.
Siegler AJ, Wirtz S, Weber S, Sullivan PS.
JMIR Public Health Surveill. 2017 Sep 6;3(3):e58.
Abstract

Barriers to Access and Adoption of Pre-Exposure Prophylaxis for the Prevention of HIV Among Men Who Have Sex With Men (MSM) in a Relatively Rural State.
Hubach RD, Currin JM, Sanders CA, et al;  
AIDS Educ Prev. 2017 Aug;29
Abstract

Estimated coverage to address financial barriers to HIV preexposure prophylaxis among persons with indications for its use, United States, 2015.
Smith DK, Van Handel M, Huggins R.
J Acquir Immune Defic Syndr. 2017 Aug 22.
Abstract

Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
Haberer JE, Kidoguchi L, Heffron R, et al
J Int AIDS Soc. 2017 Jul 25;20(1):1-
Abstract

Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
Bazzi AR, Leech AA, Biancarelli DL,  et al
AIDS Patient Care STDS. 2017 Jul 18.
Abstract

Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
Shrestha R, Karki P, Altice FL, et al
AIDS Behav
. 2017 Jul 10.
Abstract

Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013.
Walters SM, Rivera AV, Starbuck L, Reilly KH,
J  Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3:S383-S391
Abstract

Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013.
Walters SM, Rivera AV, Starbuck L, Reilly KH,
J  Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3:S383-S391
Abstract

HIV preexposure prophylaxis for adolescents and young adults.
Allen E, Gordon A, Krakower D, Hsu K.
Curr Opin Pediatr. 2017 Jun 8
Abstract

FULL-TEXT ARTICLE
I
mpact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention
Patel RR, Mena L, Nunn A
PLoS One. 2017 May 30;12(5):e0178737.
Paper

Assessing the need for a pre-exposure prophylaxis programme using the social media app Grindr®.
Hampel B, Kusejko K, Braun DL

HIV Med
.
2017 May 19
Abstract

The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States.
Adamson BJS, Carlson JJ, Kublin JG, Garrison LP.
Vaccines (Basel). 2017 May 24;5(2).

Abstract

Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project.
al L, Audsley J, Murphy D, Fairley CK, et al

AIDS
. 2017 May 1.
Abstract

Blood safety implications of donors using HIV pre-exposure prophylaxis.
Seed CR, Yang H, Lee JF
.
Vox Sang
. 2017 Mar 31
Abstract

A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up.
Anand T, Nitpolprasert C, Trachunthong D,  et al

J Int AIDS Soc
. 2017 Mar 10;20(1):1-11.
Abstract

FULL-TEXT ARTICLE
Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation.
Ross I, Mejia C, Melendez J, Chan PA,  et  al;

PLoS On
e
. 2017 Mar 3;12(3):e0173057.
Paper

FULL-TEXT ARTICLE
Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi.
Arnold T, Brinkley-Rubinstein L, et al

PLoS One
. 2017 Feb 21;12(2):e0172354
Paper

Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016.
Moreno S, Antela A, García F, Del Amo J, et al

Enferm Infecc Microbiol Clin
. 2017 Feb 21.

Abstract

Reaching Key Populations: PrEP Uptake in an Urban Health Care System in the Bronx, New York.
Bien CH, Patel VV, Blackstock OJ, Felsen UR.

AIDS Behav
. 2016 Dec 26.
Abstract

PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists.
Petroll AE, Walsh JL, Owczarzak JL,  et al
AIDS Behav. 2016 Nov 24.
Abstract

Occurrence of HIV eradication for preexposure prophylaxis treatment with a deterministic HIV model.
Chang H, Moog C,
Astolfi A.|IET Syst Biol. 2016 Dec;10(6):237-243.
Abstract

Where next with preexposure prophylaxis?
Nugent D, Gilson R. |
Curr Opin Infect Dis. 2016 Nov 18..
Abstract

Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.
Marcus JL, Hurley LB, Hare CB, Nguyen DP,
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546..
Abstract

A Preemptive Weapon.
Berlin J.
Tex Med. 2016 Nov 1;112(11):39-44.
Abstract

A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians.
Blackstock OJ, Moore BA, Berkenblit GV, et al

J Gen Intern Med. 2016 Oct 24.
Abstract

Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study.
Nichols BE, Boucher CA, van der Valk M, et al
Lancet Infect Dis. 2016 Sep 22.
Abstract

Informing Strategies to Build PrEP Capacity among San Francisco Bay Area Clinicians.
Bacon O, Gonzalez R, Andrew E, et al

J Acquir Immune Defic Syndr
.
2016 Sep 19
Abstract

Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection?
Pialoux G, Delaugerre C, Cotte L,
et al

Clin Microbiol Infect
. 2016 Sep 8
Abstract

Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database.
Rossotti R, Borghi V, Callegaro AP, et al
J Clin Virol. 2016 Aug 23;83:48-53..
Abstract

HIV-1-neutralizing IgA is detected in genital secretions of highly HIV-1 exposed seronegative women on oral pre-exposure prophylaxis.
Lund JM, Broliden K, Pyra MN, Thomas KK, et a
l
J Virol
. 2016 Aug 24.
Abstract

HIV pre-exposure prophylaxis for women and infants prevents vaginal and oral HIV transmission in a preclinical model of HIV infection.
Kovarova M, Shanmugasundaram U, Baker CE,  et al
J Antimicrob Chemother
. 2016 Aug 1.
Abstract

To whom is HIV pre-exposure prophylaxis proposed?
Ayerdi-Aguirrebengoa O, Vera-García M, Puerta-López T, et a
l
Enferm Infecc Microbiol Clin
. 2016 Jul 18.
Abstract

FULL-TEXT ARTICLE
Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting.
Montgomery MC, Oldenburg CE, Nunn AS, et al
PLoS One. 2016 Jun 22;11(6):e01577
Paper

The Potential of Pre-Exposure Prophylaxis for Women in Violent Relationships.
Braksmajer A, Senn TE, McMahon J.
AIDS Patient Care STDS
. 2016 Jun;30(6):274-81
Abstract

FULL-TEXT ARTICLE
PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015.
Smith DK, Mendoza MC, Stryker JE, Rose CE.

PLoS One
. 2016 Jun 3;11(6):e0156592.
Paper

FULl-TEXT ARTICLE
Pre-exposure prophylaxis for the prevention of HIV infection: a new prevention paradigm?
Sánchez-Rubio Ferrández J, Martínez Sesmero JM.
Farm Hosp
.
2016 May 1;40(n03):219-2
Paper

Attitudes Toward HIV Pre-Exposure Prophylaxis in a United States Urban Clinic Population.
Kwakwa HA, Bessias S, Sturgis D, et al

AIDS Behav
. 2016 Apr 26.
Abstract

PrEP as Peri-conception HIV Prevention for Women and Men.
Heffron R, Pintye J, Matthews LT, et al

Curr HIV/AIDS Rep
.
2016 Mar 18.
Abstract

'HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.
Adams LM, Balderson BH.
AIDS Care. 2016 Feb 26:1-5
Abstract

Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings
Marcus JL, Volk JE, Pinder J, et al
Curr HIV/AIDS Rep. 2016 Feb 22.
Abstract

Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public Support.
Calabrese SK, Underhill K, Earnshaw VA, et al 

AIDS Behav
. 2016 Feb 19.
Abstract

FULL-TEXT ARTICLE
Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among Individuals Living with HIV in an Urban HIV Clinic.
Jayakumaran JS, Aaron E, Gracely EJ, et al 
PLoS One. 2016 Feb 10;11(2):e0145670.
Paper

Preexposure Prophylaxis (PrEP) for HIV Prevention: The Primary Care Perspective.
Conniff J, Evensen A.
J Am Board Fam Med. 2016 Jan-Feb;29(1):143-51..
Abstract

Improving outpatient implementation of preexposure prophylaxis in men who have sex with men.
Scholl E.

J Am Assoc Nurse Pract
. 2016 Jan 27
Abstract

FULL-TEXT ARTICLE
Complex and Conflicting Social Norms: Implications for Implementation of Future HIV Pre-Exposure Prophylaxis (PrEP) Interventions in Vancouver, Canada.
Knight R, Small W, Carson A, Shoveller J.

PLoS One
. 2016 Jan 12;11(1):e0146513.
Paper

Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation.
Weis JF, Baeten JM, McCoy CO,  et al
AIDS. 2016 Jan 2;30(1):31-35.
Abstract

FULL-TEXT ARTICLE
Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand.
Suntharasamai P, Martin M, Choopanya K,  et al
PLoS One. 2015 Dec 30;10(12):e0145859.
Paper

Nondaily preexposure prophylaxis for HIV prevention.
Anderson PL, García-Lerma JG, Heneine W
.
Curr Opin HIV AIDS
.
2016 Jan;11(1):94-101.
Abstract

FULL-TEXT ARTICLE
Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection - New York, 2012-2015.
Laufer FN, O'Connell DA, Feldman I; MPS, Zucker HA.
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46)
Paper

The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA.
Elion R, Coleman M.

Curr Opin HIV AIDS
. 2015 Nov 23.
Abstract

The European preexposure prophylaxis revolution.
Cairns G, McCormack S, Molina JM.
Curr Opin HIV AIDS. 2015 Nov 23.
Abstract

What people want from sex and preexposure prophylaxis.
Grant RM, Koester KA.

Curr Opin HIV AIDS
. 2015 Nov 13
Abstract

What do we know about the cost-effectiveness of HIV preexposure prophylaxis, and is it affordable?
Cambiano V, Miners A, Phillips A.
Curr Opin HIV AIDS. 2015 Nov 13
Abstract

Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
Liu AY, Cohen SE, Vittinghoff E,  et al
JAMA Intern Med. 2015 Nov 16
Abstract

What does preexposure prophylaxis mean for treatment; what does treatment mean for preexposure prophylaxis?
Venter WD.

Curr Opin HIV AIDS
. 2015 Nov 5.
Abstract

Statistical issues in trials of preexposure prophylaxis.
Dunn DT, Glidden DV.
Curr Opin HIV AIDS. 2015 Nov 5.
Abstract

The role of healthcare providers in the roll out of preexposure prophylaxis.
Krakower DS, Mayer KH.

Curr Opin HIV AIDS
. 2015 Sep 28
Abstract

Consensus Document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children
Grupo de expertos de la Secretaría del Plan Nacional sobre el Sida (SPNS); Grupo de Estudio de Sida (GeSIDA); Sociedad Española de Medicina y Seguridad del Trabajo (SEMST); Grupo de Estudio de Sida (GeSIDA); Sociedad Española de Medicina y Seguridad del Trabajo (SEMST); Sociedad Española de Medicina Preventiva;  et al  
Enferm Infecc Microbiol Clin
. 2015 Sep 22
Abstract

FULL-TEXT ARTICLE
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
McCormack S, Dunn DT, Desai M, et al
Lancet. 2015 Sep 9.
Paper
 

Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.
Chakrapani V, Newman PA, Shunmugam M, et al

AIDS Patient Care STDS
. 2015 Sep 8.
Abstract
 

No New HIV Infections with Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
Volk JE, Marcus JL, Phengrasamy T, et al

Clin Infect Dis
. 2015 Sep 1.
Abstract
 

FULL-TEXT ARTICLE
PrEP Implementation Science: State-of-the-Art and Research Agenda.
Cáceres CF, Mayer KH, Baggaley R, O'Reilly KR.
J Int AIDS Soc. 2015 Jul 20;

Paper
 

FULL-TEXT ARTICLE
PrEP implementation: moving from trials to policy and practice.
Cáceres CF, O'Reilly KR, Mayer KH, Baggaley R.

J Int AIDS Soc
. 2015 Jul 20;18(4(Suppl 3)):20222.

Paper

 

FULL-TEXT ARTICLE
Beyond "getting drugs into bodies": social science perspectives on pre-exposure prophylaxis for HIV
Auerbach JD, Hoppe TA.
J Int AIDS Soc. 2015 Jul 20;18(4(Suppl 3)):19983.

Paper


FULL-TEXT ARTICLE
Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access
Hankins C, Macklin R, Warren M.
J Int AIDS Soc. 2015 Jul 20;18(4(Suppl 3)):19973.
Paper

 

FULL-TEXT ARTICLE
Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress.
Mayer KH, Hosek S, Cohen S, et al

J Int AIDS Soc. 2015 Jul 20;18(4(Suppl 3)):19980

Paper

 

FULL-TEXT ARTICLE
The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention.
Cáceres CF, Koechlin F, Goicochea P, et al

J Int AIDS Soc
. 2015 Jul 20;18(4(Suppl 3)):19949.  
Paper

 

FULL-TEXT ARTICLE
Pre-exposure prophylaxis in Southern Africa: feasible or not?
Venter WD, Cowan F, Black V, et al|

J Int AIDS Soc
. 2015 Jul 20;18(4(Suppl 3)):19979.

Paper

 

FULL-TEXT ARTICLE
Seasonal PrEP for partners of migrant miners in southern Mozambique: a highly focused PrEP intervention.
Cremin I, Morales F, Jewell BL, et al
J Int AIDS Soc. 2015 Jul 20;18(4(Suppl 3)):19946
Paper

 

Demographic Differences in PrEP-Related Stereotypes: Implications for Implementation.
Golub SA, Gamarel KE, Surace A.
AIDS Behav. 2015 Jul 5.

Abstract

Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.
Kuebler PJ, Mehrotra ML, McConnell JJ,  et al
Proc Natl Acad Sci U S A. 2015 Jun 22.
Abstract

 

The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Jain S, Krakower DS, Mayer KH
Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S200-4.

Abstract

Clinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in Delivery.
Doblecki-Lewis S, Cohen S, Liu A.

Curr Treat Options Infect Dis
. 2015 Jun;7(2):101-112.
Abstract

Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.
Blashill AJ, Ehlinger PP, Mayer KH, Safren SA.
Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S187-90.
Abstract

Estimating the range of potential epidemiological impact of pre-exposure prophylaxis: run-away success or run-away failure?
Cremin Í, Hallett TB.

AIDS
. 2015 Mar 27;29(6):733-738.
Abstract

Pre-Exposure Prophylaxis to Prevent HIV Infection: Current Status, Future Opportunities and Challenges.
Krakower DS, Mayer KH.

Drugs
. 2015 Feb 12
Abstract

Turning the tide against AIDS by preventing new HIV infections initial experience with Minnesota's first PrEP clinic.
Eccles-Radtke C, Henry K
Minn Med. 2015 Jan;98(1):45-8.
Abstract

Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.
Kessler J, Myers JE, Nucifora KA,  et al
AIDS. 2014 Nov 28;28(18):2683-2691.
Abstract

Pre-exposure Prophylaxis for Human Immunodeficiency Virus: The Past, Present, and Future.
Castel AD, Magnus M, Greenberg AE.
Infect Dis Clin North Am
. 2014 Dec;28(4):563-583
Abstract

Using geospatial modelling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa.
Gerberry DJ, Wagner BG, Garcia-Lerma JG,  et al
Nat Commun. 2014 Dec 2;5:5454.
Abstract

Oral preexposure prophylaxis to prevent HIV infection: Clinical and public health implications.
Baker J, OʼHara KM.
JAAPA. 2014 Nov 11
Abstract

Streamlining HIV testing for HIV Pre-exposure Prophylaxis.
Guanira JV, Leigler T, Kallas E, et al

J Clin Microbiol
. 2014 Nov 5.
Abstract

FULL-TEXT PDF ARTICLE
HIV Preexposure Prophylaxis in the Real World
Daskalakis DC.
Top Antivir Med. 2014 September/October;22(4):670-675
Paper

Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
Shaeer KM, Sherman EM, Shafiq S, Hardigan P.

J Am Pharm Asso
c (2003)
. 2014 Oct 24:e380-e387
Abstract

Role of Oral Pre-exposure Prophylaxis (PrEP) in Current and Future HIV Prevention Strategies.
Burns DN, Grossman C, Turpin J,  et al

Curr HIV/AIDS Rep
. 2014 Oct 5
Abstract

Comparing the Novel Method of Assessing PrEP Adherence/Exposure using Hair Samples to other Pharmacologic and Traditional Measures
Baxi SM, Liu A, Bacchetti P, et al

J Acquir Immune Defic
Syndr
. 2014 Oct 7.
Abstract

Non-occupational Post-exposure Prophylaxis for HIV in New York State Emergency Departments.
Fitzpatrick LJ, Egan DJ, Cowan E,
J Int Assoc Provid AIDS Care. 2014 Oct 7
Abstract

Configuring the users of new HIV-prevention technologies: the case of HIV pre-exposure prophylaxis.
Holt M.

Cult Health Sex
. 2014 Oct 1:1-12
Abstract

Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.
Blackwell CW.

Nurse Pract
. 2014 Sep 18;39(9):50-53.
Abstract

Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York City.
Kessler J, Myers JE, Nucifora KA, et aj

AIDS
. 2014 Sep 10
Abstract

FULL-TEXT ARTICLE
Preparing for PrEP: Perceptions and Readiness of Canadian Physicians for the Implementation of HIV Pre-Exposure Prophylaxis.
Sharma M, Wilton J, Senn H, et al

PLoS One
. 2014 Aug 18;9(8):e105283.
Paper

Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?
Yu W, Wang L, Han N,  et al

Artif Cells Nanomed Biotechnol
. 2014 Jul 31:1-8.
Abstract

Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE Study).
King HL, Keller SB, Giancola MA,  et al

AIDS Behav
. 2014 Jul 14
Abstract

Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.
Amico KR, Stirratt MJ.

Clin Infect Dis
. 2014 Jul 1;59 Suppl 1:S55-60
Abstract

Pharmacology lessons from chemoprophylaxis studies.
Boffito M, Jackson A, Asboe D.
Clin Infect Dis. 2014 Jul 1;59 Suppl 1:S52-4.
Abstract

Biomedical prevention: state of the science.
McCormack SM, Gafos M, et al

Clin Infect Dis
. 2014 Jul 1;59 Suppl 1:S41-6
Abstract

Antiretroviral chemoprophylaxis: state of evidence and the research agenda.
Mayer KH.

Clin Infect Dis
. 2014 Jul 1;59 Suppl 1:S47-51.
Abstract

Successful Discontinuation of the Placebo Arm and Provision of an Effective HIV Prevention Product After a Positive Interim Efficacy Result:
The Partners PrEP Study Experience.
Ndase P, Celum C, Campbell J,  et al

J Acquir Immune Defic Syndr
. 2014 Jun 1;66(2):206-12
Abstract

FULL-TEXT ARTICLE
Normal Laboratory Reference Intervals among Healthy Adults Screened for a HIV Pre-Exposure Prophylaxis Clinical Trial in Botswana.
Segolodi TM, Henderson FL, Rose CE, et al

PLoS One
. 2014 Apr 8;9(4):e93034.
Paper

Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts.
Mimiaga MJ, White JM, Krakower DS, et al

AIDS Care
. 2014 Jun;26(6):684-93.
Abstract

A Cost-effectiveness Analysis of HIV Preexposure Prophylaxis for Men Who Have Sex With Men in Australia.
Schneider K, Gray RT, Wilson DP.

Clin Infect Dis
. 2014 Apr;58(7):1027-34.
Abstract

An Overview of Antiretroviral Pre-Exposure Prophylaxis of HIV Infection.
McGowan I.
Am J Reprod Immunol. 2014 Mar 17.
Abstract

FULL-TEXT ARTICLE
Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco.
Liu A, Cohen S, Follansbee S,  et al
PLoS Med. 2014 Mar 4;11(3):e1001613.
Paper

Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.
Marcus J, Buisker T, Horvath T, et al

HIV Med
. 2014 Feb 24.
Abstract

Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK.
Whetham J, Taylor S, Charlwood L,  et al
AIDS Care. 2014 Mar;26(3):332-6.
Abstract

Preexposure prophylaxis (PrEP) of HIV infection in France: A nationwide cross-sectional study (PREVIC study).
Rosenthal E, Piroth L, Cua E, et al

AIDS Care
. 2014 Feb;26(2):176-85
Abstract

Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for?
Hankins CA.
Expert Rev Pharmacoecon Outcomes Res. 2014 Feb 19.
Abstract

FULL-TEXT ARTICLE
Pre-Exposure Prophylaxis for the Prevention of HIV Infection in High Risk Populations: A Meta-Analysis of Randomized Controlled Trials.
Jiang J, Yang X, Ye L, Zhou B, et al
PLoS One
. 2014 Feb 3;9(2):e87674

Paper

Systemic Preexposure Prophylaxis for HIV: Translating Clinical Data to Clinical Practice.
Li J, Dufrene SL, Okulicz JF.

Ann Pharmacother
. 2014 Jan 28
Abstract

The Impact of Patient Race on Clinical Decisions Related to Prescribing HIV Pre-Exposure Prophylaxis (PrEP): Assumptions About Sexual Risk Compensation and Implications for Access.
Calabrese SK, Earnshaw VA, Underhill K,  et al
AIDS Behav. 2013 Dec 24.
Abstract

FULL-TEXT ARTICLE
No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis.
Marcus JL, Glidden DV, Mayer KH,  et al
PLoS One. 2013 Dec 18;8(12):e81997.
Paper

Provider Attitudes toward Oral Pre-Exposure Prophylaxis for HIV Prevention among High-Risk MSM in Lima, Peru.
Tang EC, Sobieszczyk ME, Shu E, et al

AIDS Res Hum Retroviruse
s
. 2013 Dec 10
Abstract

FULL-TEXT ARTICLE
Analytic Review of Modeling Studies of ARV Based PrEP Interventions Reveals Strong Influence of Drug-Resistance Assumptions on the Population-Level Effectiveness
Dimitrov D, Boily MC, Brown ER, Hallett TB.

PLoS One
. 2013 Nov 25;8(11):e80927.
Paper

The development of rectal microbicides for HIV prevention.
McGowan I.

Expert Opin Drug Deliv
. 2013 Nov 25
Abstract

Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the US.
Hellinger FJ.

Pharmacoeconomics
. 2013 Nov 24.
Abstract

Rectal pre-exposure prophylaxis (PrEP).
Rohan LC, Yang H, Wang L.

Antiviral Res
. 2013 Oct 24.
Abstract

FULL-TEXT PDF ARTICLE
Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?
Molina JM, Pintado C, Gatey C, et al

BMC Med
. 2013 Aug 23;11(1):186
Paper

Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK.
Whetham J, Taylor S, Charlwood L,  et al

AIDS Care
.
2013 Jul 22.
Abstract

Study design considerations for evaluating efficacy of systemic preexposure prophylaxis interventions.
Donnell D, Hughes JP, Wang L,  et al
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S130-4.
Abstract

Preexposure Prophylaxis for HIV Prevention: Where Have We Been and Where Are We Going?
Baeten JM, Haberer JE, Liu AY, Sista N.
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S122-9.
Abstract

Preexposureprophylaxis (PrEP) of HIV infection in France: A nationwide cross-sectional study (PREVIC study).
Rosenthal E, Piroth L, Cua E, Joulié A, et al

AIDS Care
. 2013 Jun 11
Abstract

Knowledge of and opinions on HIV pre-exposure prophylaxis among front-line service providers at Canadian AIDS Service Organizations.
Senn H, Wilton J, Sharma M, et al
AIDS Res Hum Retroviruses. 2013 Jun 3
Abstract

Daily Short Message Service Surveys to Measure Sexual Behavior and Pre-exposure Prophylaxis Use Among Kenyan Men and Women.
Curran K, Mugo NR, Kurth A,  et al

AIDS Behav
. 2013 May 22.
Abstract

Racial differences and correlates of potential adoption of preexposure prophylaxis: results of a national survey.
Wingood GM, Dunkle K, Camp C, et al

J Acquir Immune Defic Syndr
. 2013 Jun;63 Suppl 1:S95-S101
Abstract

FULL-TEXT PDF ARTICLE
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists.
Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G.

BMC Infect Dis
. 2013 May 14;13(1):217
Paper

FULL-TEXT ARTICLE
The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies.
Gomez GB, Borquez A, Case KK, et al
PLoS Med
. 2013 Mar;10(3):e1001401
Paper

HIV PrEP Trials: The Road to Success.
Nicol MR, Adams JL, Kashuba AD.
Clin Investig (Lond). 2013 Mar;3(3).
Abstract

A Pill for HIV Prevention: Deja Vu All Over Again?
Myers JE, Sepkowitz KA.
Clin Infect Dis. 2013 Feb 13.
Abstract

Estimating the Efficacy of Preexposure Prophylaxis for HIV Prevention Among Participants With a Threshold Level of Drug Concentration.
Dai JY, Gilbert PB, Hughes JP, Brown ER.

Am J Epidemiol
. 2013 Jan 9
Abstract

Antiretroviral Preexposure Prophylaxis for HIV Prevention.
[No authors listed]
N Engl J Med. 2013 Jan 3;368(1):82-4

Abstract
 
Antiretroviral Preexposure Prophylaxis for HIV Prevention.
Bolland MJ, Grey A.
N Engl J Med. 2013 Jan 3;368(1):82-4.
Abstract

Antiretroviral Preexposure Prophylaxis for HIV Prevention.
Kenyon C, Colebunders R.

N Engl J Med
. 2013 Jan 3;368(1):82-4
Abstract

The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
Hankins CA, Dybul MR
Curr Opin HIV AIDS. 2012 Nov 29.

Abstract

Pre-exposure prophylaxis: where are we in Europe?
Molina J.

J Int AIDS Soc
. 2012 Nov 11;15(6):
Abstract

Are we PREPared? Quality of information available to patients in the UK about PREP on the internet.
Duncan S, Duncan C.

J Int AIDS Soc
. 2012 Nov 11;15(6):18167.
Abstract

Pharmacists as providers of HIV pre-exposure prophylaxis.
Bruno C, Saberi P.

Int J Clin Pharm
. 2012 Oct 17.
Abstract

Engaging healthcare providers to implement HIV pre-exposure prophylaxis.
Krakower D, Mayer KH
Curr Opin HIV AIDS. 2012 Oct 1.
Abstract

Oral antiretroviral chemoprophylaxis: current status.
Baeten J, Celum C.
Curr Opin HIV AIDS. 2012 Sep 7
Abstract

FULL-TEXT ARTICLE
I
nterim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61:586-9.
Paper

FULL-TEXT ARTICLE
A Qualitative Study of Provider Thoughts on Implementing Pre-Exposure Prophylaxis (PrEP) in Clinical Settings to Prevent HIV Infection.
Arnold EA, Hazelton P, Lane T, et al
PLoS One. 2012;7(7):e40603.

Paper

Preexposure Prophylaxis for HIV - Where Do We Go from Here?
Cohen MS, Baden LR.
N Engl J Med. 2012 Jul 11.
Abstract

Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana.
Thigpen MC, Kebaabetswe PM, Paxton LA, et al

N Engl J Med
. 2012 Jul 11.
Abstract

FULL-TEXT ARTICLE
The use of preexposure treatments for HIV prophylaxis.
Majid A, Redfield RR, Gilliam BL.

HIV
AIDS (Auckl)
. 2012;4:17-28. .
Paper

FULL-TEXT ARTICLE
Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study.
Wheelock A, Eisingerich AB, Gomez GB, et a

BMJ Open
. 2012 Jul 2;2(4).
Paper

FULL-TEXT ARTICLE
Willingness to Accept HIV Pre-Exposure Prophylaxis among Chinese Men Who Have Sex with Men
Zhou F, Gao L, Li S, et al.
PLoS ONE 7(3): e32329
Paper

HIV Prevention by Oral Preexposure Prophylaxis.
Heneine W, Kashuba A.
Cold Spring Harb Perspect Med. 2012 Mar;2(3):a007419.
Abstract

FULL-TEXT ARTICLE
The use of preexposure treatments for HIV prophylaxis.
Majid A, Redfield RR, Gilliam BL.
HIV AIDS (Auckl). 2012;4:17-28. .
Paper

FULL-TEXT ARTICLE
Attitudes and Acceptance of Oral and Parenteral HIV Preexposure Prophylaxis among Potential User Groups: A Multinational Study.
Eisingerich AB, Wheelock A, Gomez GB,  et al

PLoS One
. 2012;7(1):e28238.
Paper

Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?
Hurt CB, Eron JJ Jr, Cohen MS.

Clin Infect Dis
. 2011 Oct 5
Abstract

FULL-TEXT ARTICLE
2011 HIV Pre-Exposure Prophylaxis (PrEP)—A Quantitative Ethics Appraisal.
Kokolo MB, Fergusson DA, Cameron DW,  et  al
PLoS ONE 6(8): e22497.
Paper

FULL-TEXT ARTICLE
Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP).
Abbas UL, Hood G, Wetzel AW, Mellors JW.
PLoS One. 2011 Apr 15;6(4):e18165
Paper

A US Policy Perspective on Oral Preexposure Prophylaxis for HIV.
Leibowitz A, Parker K, Rotheram-Borus M.

Am J Public Health
. 2011 Apr 14
Abstract

Pre-Exposure Prophylaxis and the Promise of Combination Prevention Approaches.
Buchbinder SP, Liu A.
AIDS Behav. 2011 Feb 18.
Abstract

Oral Preexposure Anti-HIV Prophylaxis for High-Risk U.S. Populations: Current Considerations in Light of New Findings.
Myers GM, Mayer KH.

AIDS Patient Care
STDS
. 2011 Feb;25(2):63-71.
Abstract

FULL-TEXT ARTICLE
Oral Preexposure Prophylaxis for HIV - Another Arrow in the Quiver?
Michael NL.

N Engl J Med
. 2010 Nov 23
Paper

FULL-TEXT ARTICLE
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Grant RM, Lama JR, Anderson PL, et al

N Engl J Med. 2010 Nov 23.
Paper

FULL-TEXT ARTICLE
Evaluating the Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) and Its Impact on HIV-1 Transmission in South Africa.
Pretorius C, Stover J, Bollinger L, Bacaër N, Williams B.
PLoS One. 2010 Nov 5;5(11):e13646.
Paper

The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.
van de Vijver DA, Boucher CA.
Curr Opin Infect Dis. 2010 Sep 16.
Abstract

Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in Clinical Practice
Underhill K, Operario D, Skeer M, et al
J Acquir Immune Defic Syndr. 2010 Sep;55(1):8-13
Abstract

Pre-exposure Prophylaxis State of the Science: Empirical Analogies for Research and Implementation.
Golub SA, Operario D, Gorbach PM
Curr HIV/AIDS Rep. 2010 Sep 1.
Abstract

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities.
Kim SC, Becker S, Dieffenbach C,
et al
J Int AIDS Soc
. 2010 Jul 12;13(1):24
Abstract

HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.
Supervie V, García-Lerma JG, Heneine W, Blower S.

Proc Natl Acad Sci U S A
. 2010 Jul 6;107(27):12381-6
Abstract

 
     Conference Reports, Abstracts, and Posters 
 
 
Changes in the characteristics of PrEP users in the US before and after Truvada for PrEP approval
R. Mera Giler, D. Magnuson, L. Ng, et al
(XX International AIDS Conference)
Abstract

Knowledge of and experience with HIV pre-exposure prophylaxis (PrEP) among New York state healthcare providers
E. Cowan, Y. Calderon, K. Chacón, et al
(XX International AIDS Conference)
Abstract

PrEP awareness in men who have sex with men (MSM) and transgender women (TGW) assessed for participation in the US PrEP demonstration project
O. Bacon, E. Vittinghoff, S. Cohen, et al
(XX International AIDS Conference)
Abstract

Analyzing the drivers of PrEP cost-effectiveness
B. Armbruster, B. Taiwo
(XX International AIDS Conference)
Abstract

Knowledge, experience and attitudes regarding pre-exposure prophylaxis (PrEP) for HIV prevention: Is there a difference between HIV and non-HIV providers?
J. Blumenthal1 S. Jain, X. Sun, et al
(XX International AIDS Conference)
Abstract

Pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals: a meta-analysis
C.I. Okwundu, O. Uthman
(XIX International AIDS Conference)
Abstract


Ethical Challenges
     

     Journal Papers, Abstracts, and Commentaries 

 

Ethical public health issues for the use of informal PrEP.
Brisson J. 

Glob Public Health
. 2017 Sep 3:1-6
Abstract

Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial.
Dawson L, Garner S, Anude C,  et al
 
Clin Trials
. 2015 Apr 7
 

Bioethical Challenges With HIV Treatment as Prevention.
Sugarman J.

Clin Infect Dis
. 2014 Jul 1;59 Suppl 1:S32-4.
Abstract

Cultural Conundrums: The Ethics of Epidemiology and the Problems of Population in Implementing Pre-Exposure Prophylaxis.
Fiereck K.

Dev World Bioeth
. 2013 Dec 23.
Abstract

Ethics and Pre-exposure Prophylaxis for HIV Infection.
Sugarman J, Mayer KH.
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S135-9.
Abstract

Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials: Examining PrEP.
Haire B, Folayan MO, Hankins C, et al
Dev World Bioeth. 2013 May 31.
Abstract

 


Videos
     


Pre-exposure Prophylaxis for HIV Prevention Report
MWAETC: Project ECHO

 

Adherence, sexual behavior and HIV/STI incidence among men who have sex with men
(MSM) and transgender women (TGW) in the US PrEP demonstration (Demo) project
 
PrEP Adherence, Sexual Behaviors and HIV/STI Incidence
 
CROI 2015 Joanne Stekler Science of HIV PrEP

 


HIV Prevention Main Page Main New/Newsworthy Home Page

HIV Infection/Disease:
Pre-Exposure Prophylaxis